top of page

Exact Sciences and Genomic Health in a $2.8 billion deal

Exact Sciences is buying fellow cancer technologies firm Genomic Health in a $2.8 billion deal announced Monday.


If cleared by regulators, the combined company will employ roughly 1,000 people and is slated to have an R&D budget of about $200 million. The deal is expected to close by the end of 2019. 




Source: medtechdive



4 views0 comments

Recent Posts

See All

Medtech industry outlook 2021

Dear all, here are the great sources that caught our eye in the last weeks regarding the medical device industry outlook as of 2021. Including: - EY report, 2021 - McKinsey report, 2021 - MedTech Dive

Comments


bottom of page